You are here: Home > Institute of Excellence (CPD) > CPD Events > Eyerising RLRL – Latest Clinical Update and Real World Experience

Eyerising RLRL - Latest Clinical Update and Real World Experience

Date: 14/04/2026 (AEDT)

Venue: Online, VIC, 3000

Provider: Eyerising International

Contact: Di Miao, [E] info@eyerisinginternational.com, [P] 0420311021

Activity Outline

Eyerising RLRL - Latest Update and Real World Experience

Join us for an insightful webinar exploring the latest developments in Repeated Low-Level Red-Light (RLRL) therapy for myopia management. This session will provide an update on the most recent clinical evidence supporting RLRL, including new research findings and growing global clinical experience. This includes new data on a 3 year Real World Study looking at the safety and efficacy of RLRL in adolescent myopic patients and new data from Spain looking at the 12-month efficacy and safety of combinational RLRL with orthokeratology treatment. 

We are also pleased to feature optometrist Vivien Ta, who will share real-world case studies from her clinic, offering practical insights into how RLRL is being implemented in everyday clinical practice and the outcomes observed in patients.

Key topics include:

    - Latest clinical data and research updates on RLRL

    Real-world clinical experience and patient outcomes

    - Practical insights from frontline clinical use

    - Discussion on the role of RLRL in modern myopia management

This webinar is designed for eye care professionals interested in understanding the evolving evidence, practical application, and real-world impact of RLRL in managing progressive myopia.

Learning Objectives

  • Describe the mechanism and clinical rationale of Repeated Low-Level Red-Light (RLRL) therapy in the management of progressive myopia
  • Summarise recent clinical evidence on the safety and efficacy of RLRL therapy, including findings from recent multi-year real-world studies in adolescent myopic patients. Interpret emerging evidence on combination therapy approaches, including the use of RLRL alongside orthokeratology for myopia control.
  • Evaluate real-world clinical outcomes from RLRL implementation in an optometric practice setting through case studies.
  • Identify practical considerations for integrating RLRL therapy into clinical practice, including patient selection, monitoring, and treatment adherence and be able to discuss the role of RLRL within the broader landscape of myopia management strategies, including how it may complement existing interventions.

Max CPD hours awarded: 0.5

Session Information

Name
Eyerising International - Latest RLRL Clinical Update
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
RLRL Real Word Case Study - An Optometrist's First Hand Experience
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.